Replies to post #182921 on Biotech Values

[IanFromSI]

Perhaps the company believes their tx will actually reverse the effects of AD. ???

Well, they could at least go for mild to moderate, not the moderate to sever AD patients, as the latter are too far progressed to gain from any treatment.